Herpes simplex virus (HSV) is a ubiquitous organism that causes infections in human populations throughout the world. It causes a variety of diseases ranging in severity from mild to life-threatening. In this study, ent-epiafzelechin-(4α→8)-epiafzelechin (EEE) extracted from the fresh leaves of Cassia javanica L. agnes de Wit (Leguminosae) was investigated for its in vitro anti-HSV-2 activity using XTT and plaque reduction assays. Results showed that EEE inhibited HSV-2 replication in a dose-dependent manner. The IC50 value was 83·8±10·9 and 166·8±12·9 μM for XTT and plaque reduction assays, respectively. EEE did not affect the viability and the proliferation of cells at antiviral concentrations. Mechanistic studies demonstrated that EEE prevented HSV-2 from penetrating the cell and also interfered with HSV-2 replication at the late stage of its life cycle. It also disturbed virus attachment but the inhibitory effect was minor. In summary, the conclusion of this study was that EEE exhibits various modes of action in suppressing HSV-2 multiplication.
AlbinR.,
ChaseR.,
RisanoC. & 13 other authors; 1997; SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Res 35:139–146[CrossRef]
AurelianL.2000; Herpes simplex virus. In Clinical Virology Manual pp 384–409 Edited by
SpecterS.,
HodinkaR. L.,
YoungS. A.
Washington, DC: American Society for Microbiology;
BoulwareS. L.,
BronsteinJ. C.,
NordbyE. C.,
WeberP. C.2001; Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antiviral Res 51:111–125[CrossRef]
CarlucciM. J.,
CianciaM.,
MatulewiczM. C.,
CerezoA. S.,
DamonteE. B.1999; Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antiviral Res 43:93–102[CrossRef]
ChengH. Y.,
LinC. C.,
LinT. C.2002a; Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res 55:447–455[CrossRef]
ChengH. Y.,
LinT. C.,
IshimaruK.,
YangC. M.,
WangK. C.,
LinC. C.2003; In vitro antiviral activity of prodelphinidin B-2 3, 3′-di- O -gallate from Myrica rubra
. Planta Med 69:953–956[CrossRef]
ChengH. Y.,
LinT. C.,
YangC. M.,
WangK. C.,
LinL. T.,
LinC. C.2004a; Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage of replication of herpes simplex virus type 2 in vitro
. J Antimicrob Chemother 53:577–583[CrossRef]
ChengH. Y.,
LinT. C.,
YangC. M.,
WangK. C.,
LinC. C.2004b; Mechanism of action of the suppressing of herpes simplex virus type 2 replication by pterocarnin A. Microbes Infect 6:738–744[CrossRef]
Chinese Herbal Commission of the National Administrative Department on Chinese Medicine & Pharmacy1999Chinese Herbal Shanghai: Shanghai Science & Technology Press;
De LoguA.,
LoyG.,
PelleranoM. L.,
BonsignoreL.,
SchivoM. L.2000; Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res 48:177–185[CrossRef]
EnglundJ. A.,
ZimmermanM. E.,
SwierkoszE. M.,
GoodmanJ. L.,
SchollD. R.,
BalfourH. H.Jr1990; Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Ann Intern Med 112:416–422[CrossRef]
KashiwadaY.,
IizukaH.,
YoshiokaK.,
ChenR. F.,
NonakaG. I.,
NishiokaI.1990; Tannins and related compounds. XCIII. Occurrence of enantiomeric proanthocyanidins in the Leguminosae plants, Cassia fistula L. and C. javanica L. Chem Pharm Bull 38:888–893[CrossRef]
KleymannG.,
FischerR.,
BetzU. A. & 20 other authors; 2002; New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat Med 8:392–398[CrossRef]
LiuzziM.,
DezielR.,
MossN. & 11 other authors; 1994; A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo
. Nature 372:695–698[CrossRef]
NugierF.,
ColinJ. N.,
AymardM.,
LangloisM.1992; Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a 2-year sensitivity screening survey. J Med Virol 36:1–12[CrossRef]
RoizmanB.,
SearsA. E.1996; Herpes simplex viruses and their replication. In Virology, 3rd edn. pp 2231–2295 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott-Raven Publishers;
SmithJ. S.,
RobinsonN. J.2002; Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186:S3–S28[CrossRef]
WeislowO. S.,
KiserR.,
FineD. L.,
BaderJ.,
ShoemakerR. H.,
BoydM. R.1989; New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81:577–586[CrossRef]